Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspective.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 24059369.
- Also identified by DOI 10.2214/AJR.12.10003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this article is to review the decade-long experience with imatinib and other molecular targeted agents in the treatment of gastrointestinal stromal tumor (GIST). Tremendous progress has been made in the medical management of GIST since the inception of imatinib, and imaging has played a key role in understanding the typical and atypical responses of GIST to molecular targeted therapies.
Medical subject headings
- Benzamides
- Gastrointestinal Neoplasms
- Gastrointestinal Stromal Tumors
- Multimodal Imaging
- Piperazines
- Positron-Emission Tomography
- Pyrimidines
- Tomography, X-Ray Computed